title: Primary progressive multiple sclerosis--why we are failing.
authors.affiliation: Department of Neurology, University of Michigan, MI, USA; Neurology Section, VA Ann Arbor Health Care Systems, Ann Arbor, MI, USA.
authors.forename: Benjamin M
authors.initials: BM
authors.lastname: Segal
authors.affiliation: Neurology Section, VA North Texas Health Care System, Medical Service Dallas, VA Medical Center, Dallas, TX, 75216, USA; Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA; Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. Electronic address: olaf.stuve@utsouthwestern.edu.
authors.forename: Olaf
authors.initials: O
authors.lastname: Stüve
mesh_terms: D005260:Female; D000068876:Fingolimod Hydrochloride / Q000008:administration & dosage*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D020528:Multiple Sclerosis, Chronic Progressive / Q000188:drug therapy*
chemical_list: D007166:Immunosuppressive Agents; D000068876:Fingolimod Hydrochloride